Researchers at UNC are pursuing the use of lab-made monoclonal antibodies as a viable, affordable contraceptive, and recently published study results that tested viability of the technology on sheep.
Read More
Our latest exclusive events wrapup summarizes the must-attend happenings across the Triangle in September, including industry-specific meetups, informative workshops, conferences, panels, and more. Here’s the latest, adjusted for coronavirus cancellations and changes.
Read More
The new money is in addition to the roughly $2 million raised last month, noted in a separate filing. Fifteen investors contributed to the round, which kicked off Aug. 18. The Carrboro-based firm is still seeking to raise another $725,000 million, the filing noted.
Read More
Inhalon Biopharma, headed by associate professor Sam Lai and his team at UNC Eshelman School of Pharmacy, is developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
Read More
The upcoming PharmSci conference on March 3 will feature talks and panels discussing open science and its impact on medical research and drug discovery. Here’s a preview.
Read More
UNC-Chapel Hill pharmacy professor Sam Lai’s startup companies use muco-trapping antibody tech to fight infections and enable non-hormonal contraception.
Read More
